16 Nov 2021
The European Medicines Agency has approved once-weekly administration of lonapegsomatropin (TransCon hGH, Ascendis Pharma) for 3-18 year olds to treat growth hormone deficiency.
New study suggests interacting with dogs can reduce cortisol levels
15 Mar 2024
Diabetes risk may be reduced by prioritising plant-based food
15 Mar 2024
Obesity in primary school aged girls linked to high incidence of musculoskeletal symptoms
15 Mar 2024
Risk of endometrial cancer associated with endocrine disrupting chemicals (EDCs)
15 Mar 2024